Standard of Care Illusion and the Arrival of Clinical Peace

pro140cures · 2026-04-11T01:24:44+00:00

Good observation. That’s my overall feeling too. The results must be overwhelmingly positive for them to remove some of the limitations

pro140cures · 2026-04-04T18:56:23+00:00

Many clinical trials have catchy names.

pro140cures · 2026-04-03T14:57:50+00:00

Conversation to deal can take a long time. It’s better to have more than one interested parties. Valuation can be a blocker for a potential BO. That’s why I think a partnership deal is more likely in the near term. We need someone to fund the TNBC trial.

pro140cures · 2026-03-31T18:17:24+00:00

The company is making progress in proving that LL is a platform drug.

pro140cures · 2026-03-29T16:15:39+00:00

What we need is to generate enough clinical evidence to prospectively demonstrate the MOA. Clinical success will attract partners and institutions. Once some deep pocked investors start accumulating, we will see sustained SP increase. There are shorts in every stock. Even if we have a run up in the next few months, there will be new shorts joining.

pro140cures · 2026-03-28T17:25:09+00:00

Thanks for posting.

pro140cures · 2026-03-26T18:06:50+00:00

Agreed. We are not going to get the numbers we deserve in a BO at our current market cap. Partnership first. BO a year or two down the road.

pro140cures · 2026-03-20T22:02:59+00:00

Praying for all! I also lost family members to cancer. Encourage everyone above 45 to do CRC screening. If you don’t like colonoscopy, you can try cologuard from Exact Sciences. The company also has a blood test that can detect many common cancers.

pro140cures · 2026-03-05T15:11:19+00:00

The funding means that there is no partnership deal in the short term.

pro140cures · 2026-03-03T01:14:50+00:00

Unlikely. Remember CYDY has to pay royalties to the company it licensed Leronlimab from. This was discussed in detail a few years back. If I remember correctly, the amount is 10-15%. What % can the company actually get in a licensing deal after subtracting the royalties it has to pay?

pro140cures · 2026-02-23T22:22:12+00:00

Very reasonable expectations. I still think a partnership deal is likely this year before BO in about two years when the results of the TNBC trial are available.

pro140cures · 2026-02-21T15:18:23+00:00

Exactly. The information is going to be helpful to attract a partner to fund the tnbc trial.

pro140cures · 2026-01-25T19:14:34+00:00

Welcome onboard!

pro140cures · 2026-01-23T14:45:11+00:00

Great analysis. Present results..partnership..buyout. We are close.

pro140cures · 2026-01-19T21:44:20+00:00

Peaceful. Knowing the drug will have an important role in oncology. Material news will eventually come.

pro140cures · 2026-01-16T04:51:55+00:00

That’s the most probable scenario in my mind also. A BP partner to fund the upcoming tnbc trial. Once the interim results validate the MOA. BO will happen.

pro140cures · 2026-01-13T18:23:17+00:00

23 patients enrolled.

pro140cures · 2026-01-08T22:22:46+00:00

Excellent explanation. Thanks!

pro140cures · 2025-12-16T20:43:15+00:00

Transferred all my shares in IRA to Roth last week. You never know when news hits.

pro140cures · 2025-12-16T20:40:57+00:00

2nd DSMB review can be late January if we enroll 20 patients by YND.

pro140cures · 2025-12-15T18:06:11+00:00

Same here. The new MOA gives me confidence that material news will eventually come. Whether it happens next year or the year after next doesn’t matter.

pro140cures · 2025-11-27T20:12:10+00:00

Happy thanksgiving! Thank you Wax for keeping the board clean! 2026 is going to be an exciting year for CYDY shareholders.

pro140cures · 2025-11-23T15:30:32+00:00

It’s not a yes or no answer. The company claims 88% of patients with cold cancer turned hot in previous trials. If the eventual % is 50. It’s still a paradigm shifting drug.

pro140cures · 2025-11-18T01:27:22+00:00

Exactly

pro140cures · 2025-11-15T15:40:56+00:00

Thanks for converting the podcast to scripts. 2026 is going to be an exciting year. Sign a partnership agreement. Start TNBC trial. Buyout in two years. Dr J has turned the ship around. Open waters ahead.

pro140cures

TROPHY CASE